RECORD // Company

Aspira Women's Health Inc.

Formerly: VERMILLION, INC.; CIPHERGEN BIOSYSTEMS INC

Built 2026-11-22T00:40:28Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)
Records under a former name (3)

The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.

Matched by name only, not merged (8)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Vermillion · East food · name equals 'Vermillion' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ASPIRA WOMENS HEALTH INC · East spend · same registered legal name as 'Aspira Women's Health Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • VERMILLION · Epa echo · name equals 'Vermillion' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • VERMILLION · Epa echo · name equals 'Vermillion' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • VERMILLION · Epa rcra · name equals 'Vermillion' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • VERMILLION (TOWNSHIP OF) · Fema pa · name equals 'Vermillion' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • VERMILLION · Food sw · name equals 'Vermillion' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • VERMILLION LLC · Ny corps · name equals 'Vermillion' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare

3 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0000926617-26-000060

ItemValuePeriodFormFiledAccessionReport
Revenue$11,0003 months ended 2026-09-3010-Q2026-11-160000926617-26-0000602026-11-22 00:40 UTCReport an error
Net income (loss)$339,0003 months ended 2026-09-3010-Q2026-11-160000926617-26-0000602026-11-22 00:40 UTCReport an error
Cash and cash equivalents$12,000at 2026-09-3010-Q2026-11-160000926617-26-0000602026-11-22 00:40 UTCReport an error

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0000926617
Ticker
AWHL
EIN
330595156
CUSIP
04537Y208
Record ID
sx:sec:0000926617

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

21 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 00:40 UTCReport an error
SIC industry2835 In Vitro & In Vivo Diagnostic Substances2026-11-16SEC EDGAR company profile2026-11-22 00:40 UTCReport an error
State of incorporationDE2026-11-16SEC EDGAR company profile2026-11-22 00:40 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 00:40 UTCReport an error
Business address12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 787382026-11-16SEC EDGAR company profile2026-11-22 00:40 UTCReport an error
ExchangesOTC2026-11-16SEC EDGAR company profile2026-11-22 00:40 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$343,0002025-12-3110-K, XBRL Revenues2026-11-22 00:40 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-12,780,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 00:40 UTCReport an error
Total assets (at 2025-12-31)$5,456,0002025-12-3110-K, XBRL Assets2026-11-22 00:40 UTCReport an error
Stockholders' equity (at 2025-12-31)$-6,932,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 00:40 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$1,755,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:40 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-7,029,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:40 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$16,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:40 UTCReport an error
Long-term debt (at 2025-12-31)$1,277,0002025-12-3110-K, XBRL LongTermDebt2026-11-22 00:40 UTCReport an error
Operating lease liabilities (at 2025-12-31)$1,239,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 00:40 UTCReport an error
Form D total offering amount (D filed 2026-06-22)$1,485,0002026-06-22D2026-11-22 00:40 UTCReport an error
Form D total amount sold (D filed 2026-06-22)$1,485,0002026-06-22D2026-11-22 00:40 UTCReport an error
Form D industry groupBiotechnology2026-06-22D2026-11-22 00:40 UTCReport an error
Form D revenue rangeDecline to Disclose2026-06-22D2026-11-22 00:40 UTCReport an error
Form D date of first sale2026-06-052026-06-22D2026-11-22 00:40 UTCReport an error
8-K Item 4.02 (filed 2026-11-16)Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review On November 13, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of Aspira Women’s Health Inc. (the “Company”), after discussion with management and the Company’s independent registered public accounting firm, concluded that the Company’s previously issued unaudited Condensed Consolidated Financial Statements as of and for the three and six months ended March 31, and June 30, 2026 (the “Affected Periods”) included in the Company’s Quarterly Reports on Form 10-Q filed on May 15, 2026, and August 14, 2026, should no longer be relied upon due to material…2026-11-16SEC EDGAR 8-K 0000926617-26-000058 (text as filed, excerpt)2026-11-22 00:40 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.